Cargando…
Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of leading malignant cancers of gastrointestinal tract worldwide. Until now, the involved mechanisms during the development of ESCC are largely unknown. This study aims to explore the driven-genes and biological pathways in ESCC. METHODS:...
Autores principales: | Yang, Wanli, Zhao, Xinhui, Han, Yu, Duan, Lili, Lu, Xin, Wang, Xiaoqian, Zhang, Yujie, Zhou, Wei, Liu, Jinqiang, Zhang, Hongwei, Zhao, Qingchuan, Hong, Liu, Fan, Daiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530124/ https://www.ncbi.nlm.nih.gov/pubmed/31139019 http://dx.doi.org/10.1186/s12935-019-0854-6 |
Ejemplares similares
-
Identification of hub genes and outcome in colon cancer based on bioinformatics analysis
por: Yang, Wanli, et al.
Publicado: (2018) -
EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma
por: Duan, Lili, et al.
Publicado: (2020) -
Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes
por: Duan, Lili, et al.
Publicado: (2021) -
Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis
por: Yang, Wanli, et al.
Publicado: (2021) -
Molecular mechanisms and clinical implications of miRNAs in drug
resistance of colorectal cancer
por: Duan, Lili, et al.
Publicado: (2020)